Di Zhang
Observed names: D. Zhang, DI ZHANG, Zhang Di, Zhang, Di
Observed institutions: University of North Carolina at Charlotte, Qingdao University, Hebei Medical University, Tongji University, Beijing Tongren Hospital, National Institutes of Health, United States Food and Drug Administration, Center for Drug Evaluation and Research, Shandong University of Traditional Chinese Medicine, Binzhou Medical University, Shandong University, Harbin Medical University, Sun Yat-sen University, Guangxi Medical University, University of California, Los Angeles, University of Pittsburgh, Second Military Medical University, Shanghai Jiao Tong University, Capital Medical University, South China Normal University, Jilin University, Anhui Medical University, Chinese Academy of Sciences, Nantong University, Chinese Academy of Medical Sciences & Peking Union Medical College, Fudan University, Anhui University of Traditional Chinese Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Renji Hospital, Shandong Normal University, Tianjin Medical University General Hospital, Chinese PLA General Hospital, Shaoguan University, Westlake University, Wuhan University, Affiliated Hospital of Nantong University, Third Hospital of Hebei Medical University, Sixth Affiliated Hospital of Sun Yat-sen University, Shanghai Changzheng Hospital, Bethune Second Hospital, Liaoning Provincial People's Hospital, Nanjing Drum Tower Hospital, Gannan Medical University, Changhai Hospital, Affiliated Hospital of Qingdao University, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, National Cancer Institute, Institute of Genetics and Developmental Biology, First Affiliated Hospital of GuangXi Medical University, Frederick National Laboratory for Cancer Research, Second Affiliated Hospital of Xi'an Jiaotong University, Shanghai Tenth People's Hospital, Second Affiliated Hospital of Harbin Medical University, First Affiliated Hospital of Gannan Medical University, First Affiliated Hospital of Anhui Medical University, National Institutes for Food and Drug Control, Highlight Therapeutics (Spain), Renmin Hospital of Wuhan University, National Cancer Institute, Cancer Hospital of Chinese Academy of Medical Sciences, Peking University Third Hospital, Xuzhou No.1 People's Hospital, Beijing Children’s Hospital, Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine, Center for Cancer Research, Toshiba (United States), Bioarray Genetics (United States), First Affiliated Hospital of Zhengzhou University, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Liaocheng People's Hospital, Chinese People's Liberation Army, Qilu Hospital of Shandong University, Shandong First Medical University, TauRx (United Kingdom), First Hospital of Qinhuangdao, Wuhan University of Science and Technology, 3D Medicines, Inc. (China), Bozhou Vocational and Technical College, Chengdu University of Traditional Chinese Medicine, Zhejiang University of Technology, Tianjin Medical University, Yangzhou University, Henan Medical University, Nanjing Medical University, Xi'an Jiaotong University, Nanjing University, China Medical University
ORCID: 0000-0002-2342-5779
Observed ORCID: 0000-0002-2342-5779
OpenAlex ID: A5100366387